Clinical Trial Update: The Appropriate Anticoagulation Duration for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism [NA]

View source ↗

Summary

This clinical trial update investigates the appropriate duration of anticoagulation therapy for patients with chronic obstructive pulmonary disease and pulmonar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Embolism

Snippet

Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital | Conditions: COPD Exacerbation, PTE - Pulmonary Thromboembolism | NA | Status: UNKNOWN